Metastatic Breast Cancer, Triple Negative Breast Cancer Not Yet Recruiting Phase 2 Trials for Carboplatin (DB00958)

Also known as: Metastatic Triple-negative Breast Cancer / Metastatic Triple Negative Breast Cancer / Triple-negative Metastatic Breast Cancer / Triple Negative Metastatic Breast Cancer

IndicationStatusPhase
DBCOND0074793 (Metastatic Breast Cancer, Triple Negative Breast Cancer)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04739670Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast CancerTreatment